Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.2K
Overview
45.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

207
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
207
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Viral Mutations00:36

Viral Mutations

32.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.7K
Infection01:20

Infection

8.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.6K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

62.9K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The adaptive plasticity of temperate phage <i>λ</i>.

Virus evolution·2026
Same author

Social cues drive the evolution of plastic pathogen virulence in spatially and temporally variable environments.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The interplay between migration and selection on the dynamics of pathogen variants.

Journal of the Royal Society, Interface·2026
Same author

Pathogen host jump risk is not predicted by spillover rate, but rather by novelty.

PLoS biology·2026
Same author

Developing monoclonal antibody therapies for measles could lead to adverse pathogen evolution.

PLoS biology·2026
Same author

Lethal mutagenesis and the transient within-host dynamics of viral adaptation.

Virus evolution·2025
Same journal

The human claustrum supports cognitive networks for externally and internally driven task demands.

PLoS biology·2026
Same journal

Unusual decay: Recombination loss leads to splicing errors in green algae.

PLoS biology·2026
Same journal

Angptl5 restricts primitive hematopoiesis by promoting retinoic acid signaling in zebrafish.

PLoS biology·2026
Same journal

Engineered bipaternal mice reveal the consequences of life without a maternal genomic contribution.

PLoS biology·2026
Same journal

Multiple adhesion molecules act together in oligodendrocyte-mediated axonal selection and myelin formation.

PLoS biology·2026
Same journal

Splicing deficiency is driven by genomic erosion in non-recombining algal mating-type chromosomes.

PLoS biology·2026
See all related articles

Related Experiment Video

Updated: Aug 27, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K

Pathogen evolution during vaccination campaigns.

Troy Day1, David A Kennedy2, Andrew F Read2,3

  • 1Department of Mathematics and Statistics, Department of Biology, Queen's University, Kingston, Ontario, Canada.

Plos Biology
|September 23, 2022
PubMed
Summary
This summary is machine-generated.

Global vaccination against SARS-CoV-2 may influence viral evolution. This essay reviews pathogen evolution research related to immune priming to predict future Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) changes.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.1K

Related Experiment Videos

Last Updated: Aug 27, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.1K

Area of Science:

  • Virology
  • Evolutionary Biology
  • Immunology

Background:

  • The widespread vaccination campaign against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) raises questions about its evolutionary trajectory.
  • Understanding pathogen evolution under immune pressure is crucial for predicting future viral dynamics.

Purpose of the Study:

  • To review existing knowledge on pathogen evolution influenced by immune priming.
  • To provide insights into the potential future evolution of SARS-CoV-2.

Main Methods:

  • Literature review of studies on pathogen evolution and immune priming.
  • Synthesis of findings from research on various pathogen species.

Main Results:

  • Immune priming, including vaccination, can exert selective pressures on pathogens.
  • Evolutionary responses of pathogens to immune pressure vary depending on the pathogen and host immune landscape.

Conclusions:

  • The evolution of SARS-CoV-2 will likely be shaped by global vaccination efforts.
  • Further research is needed to anticipate and manage SARS-CoV-2 evolution in response to widespread immunity.